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Summary Some	strains	of	the	protozoan	parasite	Leishmania	guyanensis	(L.g)	harbor	a	viral	endosymbiont	called	Leishmania	RNA	virus	1	(LRV1).	LRV1	recognition	by	TLR-3	increases	parasite	burden	and	lesion	swelling	in	vivo.	However,	the	mechanisms	by	which	anti-viral	innate	immune	responses	affect	parasitic	infection	are	largely	unknown.	Upon	investigating	the	mammalian	host’s	response	to	LRV1,	we	found	that	miR-155	was	singularly	and	strongly	upregulated	in	macrophages	infected	with	LRV1+	L.g	when	compared	to	LRV1−	L.g.	LRV1-driven	miR-155	expression	was	dependent	on	TLR-3/TRIF	signaling.	Furthermore,	LRV1-induced	TLR-3	activation	promoted	parasite	persistence	by	enhancing	macrophage	survival	through	Akt	activation	in	a	manner	partially	dependent	on	miR-155.	Pharmacological	inhibition	of	Akt	resulted	in	a	decrease	in	LRV1-mediated	macrophage	survival	and	consequently	decreased	parasite	persistence.	Consistent	with	these	data,	miR-155-deficient	mice	showed	a	drastic	decrease	in	LRV1-induced	disease	severity,	and	lesional	macrophages	from	these	mice	displayed	reduced	levels	of	Akt	phosphorylation.		
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Introduction 
 
Macrophages are host cells for several obligate intracellular protozoan parasites 
such as Leishmania spp, Trypanosoma cruzi and Toxoplasma gondii (Sacks and 
Sher, 2002). Upon infection, macrophages shape the early phases of immunity by 
sensing pathogen-associated molecular patterns (PAMPs) through pathogen 
recognition receptors (PRRs). The family of Toll-like receptors (TLRs) is one of the 
most intensively studied classes of PRRs. The engagement of TLRs to their cognate 
ligands leads to a cascade of events including the recruitment of various adaptor 
molecules such as myeloid differentiation primary response gene 88 (MyD88), 
MyD88 adaptor-like, TIR-domain containing adaptor-inducing IFN-β (TRIF), and the 
TRIF-related adaptor molecule. The MyD88 adaptor protein is involved in the 
signaling of all TLRs except the double-stranded RNA (dsRNA) receptor TLR-3, 
which exclusively recruits TRIF. Both MyD88-dependent and –independent TLR 
pathways transduce signals through conserved inflammatory signaling pathways, 
inducing Interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) secretion.	TLR 
stimulation also promotes the activation of phosphatidylinositol 3-kinase (PI3K)/Akt. 
In addition to these pathways, TRIF-dependent TLR signaling induces the 
phosphorylation of interferon response element 3 (IRF-3), leading to the transcription 
of IFN-β (Rakoff-Nahoum and Medzhitov, 2009).  
TLR activation of innate cells is involved in the development of parasiticidal immunity 
by presenting parasitic antigens to T cells (Iwasaki and Medzhitov, 2004). Antigen-
activated CD4+ T cells are a major source of IFN-γ, which is a key mediator of anti-
Leishmania effector genes in macrophages (Bogdan et al., 2000). However, 
excessive TLR simulation can be detrimental to the host in chronic infectious 
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diseases by leading to progressive tissue damage and fatal systemic disorders. For 
example, TLR-3 recognition of an endosymbiotic dsRNA virus within Leishmania 
guyanensis (L.g) increases the virulence of its microbial host and induces a hyper-
inflammatory response by exploiting the innate recognition of its mammalian host 
(Ives et al., 2011).  
In addition to initiating inflammation and adaptive immunity, TLRs are known to be 
involved in macrophage survival (Lombardo et al., 2007). Certain bacterial species 
hinder TLR-4 mediated cell survival factors to induce macrophage apoptosis, 
proposing a mechanism for bacterial immune evasion (Hsu et al., 2004; Park et al., 
2005). Several viral species are reported to extend the host cell viability by inducing 
the PI3K/Akt signaling pathway to achieve latent and/or chronic infection  (Cooray, 
2004). Similarly, intracellular protozoan parasites can promote host cell survival by 
activating pro-survival signaling pathways or interrupting the host cell apoptotic 
machinery (Heussler et al., 2001). For example, infection of a murine macrophage 
cell line with Leishmania spp. induces PI3K/Akt signaling and grants them protection 
against apoptosis (Ruhland et al., 2007). Taken together, the subtle equilibrium 
between death and survival of innate cells has a determining impact on the outcome 
of microbial infections.  
Akt, a member of the protein kinase B family, is a serine threonine kinase that 
regulates numerous substrates involved in cell survival, cellular growth and 
metabolism. For instance, TLR-3-induced endogenous phosphorylation of Akt in 
primary murine macrophages leads to the degradation of Forkhead box O3 
(Foxo3a), a transcription factor that regulates genes involved in cell death (Litvak et 
al., 2012). Furthermore, Akt positively regulates the mammalian target of rapamaycin 
1 (mTOR1), which plays a key role in cell survival and growth by modulating mRNA 
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translation and many cellular processes in innate cells (Weichhart et al., 2015). The 
activating serine 2448 phosphorylation of mTOR1 by Akt leads to the 
phosphorylation of ribosomal protein S6 kinase (S6K), which promotes mRNA 
translation (Huang and Houghton, 2003).  
Another important component of TLR stimulation is the expression of small non-
coding RNAs, named microRNAs, which regulate genes at the post-transcriptional 
level, culminating in the degradation of the transcript or the inhibition of translation 
(Valencia-Sanchez et al., 2006). In macrophages, microRNA-155 (miR-155) is the 
only microRNA that is significantly up-regulated in response to 
polyinosinic:polycytidylic acid (poly I:C), a synthetic dsRNA ligand for TLR-3	
(O'Connell et al., 2007). MiR-155 is also classified as an oncogenic microRNA. The 
overexpression of miR-155 in mice causes a myeloid proliferative disorder, which is 
at least partially due to Akt-mediated cell survival and proliferation (O'Connell et al., 
2008), indicating the oncogenic potential of a TLR-induced microRNA.  
In this study, we asked which microRNAs were modulated in macrophages in the 
presence of L.g endosymbiont LRV1 and investigated how and by which 
mechanism(s) LRV1 contributed to increased pathology. 
 
Results 
 
MiR-155 is the uniquely expressed microRNA due to LRV1/TLR-3/TRIF 
signaling 
To determine the impact of LRV1 on the miRNA expression profile, murine bone-
marrow macrophages (BMMs) were incubated with LRV1+ L.g or LRV1- L.g 
parasites for 10 hours followed by a miRNA microarray analysis performed on total 
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RNA. Out of 1179 miRNAs, miR-155 was the only miRNA significantly up-regulated 
by LRV1+ L.g infection in comparison to LRV- L.g (Figure 1A). To verify this result, 
isolated RNA from LRV1+ L.g or LRV1- L.g infected macrophages was reverse 
transcribed into complementary DNA (cDNA) using a stem-loop primer approach 
(Hurley et al., 2012). cDNAs were then used to quantify mature miR-155 by real-time 
PCR (RT-PCR). Consistent with the microRNA microarray data, miR-155 was 
drastically up-regulated in response to poly I:C treatment and LRV1+ L.g infection 
(Figure 1B). These findings demonstrated that the dsRNA endosymbiont within L.g 
altered the miRNAome profile of host macrophages and induced the expression of 
miR-155.  
MiR-155 is located in third exon of the non-protein coding B cell integrated cluster 
(BIC) gene (Tam, 2001). To examine the kinetics of miR-155 induction in BMMs 
following various stimuli, the expression of both BIC mRNA and the mature form of 
miR-155 were monitored for 24 hours post-infection using RT-PCR. In the presence 
of LRV1 or poly I:C, miR-155 and BIC gene were detected after 2 hours, with a peak 
at 10 hours post-infection (Figures 1C-D). MiR-155 expression stabilized after 10 
hours post-incubation, while the transcript level of BIC was strongly down-regulated 
in macrophages incubated with LRV1+ L.g and poly I:C after 24 hours (Figures 1C-
D). Upon LRV1- L.g infection, BIC remained almost undetectable during the 24-hour 
time course (Figures 1D). In miR-155-/- deficient mice, a β-galactosidase reporter 
gene replaces the third exon of BIC allowing the measurement of BIC promoter 
activity (Thai et al., 2007). LRV1+ L.g and LRV1- L.g infected miR-155-/- BMMs were 
lysed and cell lysates were tested for β-galactosidase by immunoblotting (Figure 
1E). We observed that the β-galactosidase level peaked after 10 hours incubation 
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with LRV1+ L.g or poly I:C. Comparatively, LRV1- L.g infection induced residual β-
galactosidase expression (Figure 1E).   
The LRV1 dsRNA genome is an agonist of TLR-3, which signals through TRIF 
adaptor protein (Ives et al., 2011). To investigate whether LRV promotes miR-155 
expression through the TLR-3/TRIF signaling pathway, BMMs derived from WT, 
TLR3-/-, and TRIFΔLPS2 were infected with LRV1+ L.g or LRV1- L.g. Poly I:C treatment 
was used as a positive control. Both LRV1 and poly I:C-induced miR-155 expression 
required functional TLR-3 and TRIF molecules since the ablation of either TLR-3 or 
TRIF abrogated miR-155 expression (Figure 1F). These data indicated that the TLR-
3/TRIF signaling pathway initiated the expression of miR-155 upon sensing LRV1 or 
synthetic dsRNA.  
 
LRV1 mediated miR-155 expression confers increased parasite burden and 
severity of pathology in mice 
The role of miR-155 in the development of disease pathology was evaluated in vivo 
by infecting WT and miR-155-/- mice in the footpad. A drastic decrease in footpad 
swelling and reduced parasite burden was observed in miR-155-/- mice infected with 
LRV1+ L.g at the peak of infection (Figures 2A-B). In the case of LRV1- L.g 
infection, no significant difference in disease pathology was detected between WT 
and miR-155-/- mice (Figures 2A-B). These findings suggested that LRV1 mediated 
host miR-155 expression played a crucial role in the survival of LRV1+ L.g parasites 
in mice.    
Since miR-155 has also been shown to be required for the normal function of B cells 
and antibody secretion (Rodriguez et al., 2007; Thai et al., 2007), we decided to 
determine the impact of B cells on L.g infection. WT mice and mice lacking mature B 
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cells (Jh-/-) were infected with LRV1+ L.g. Infected WT and B cell deficient mice 
displayed similar footpad swelling and parasitemia profiles (Figures S1A and S1B). 
We additionally examined B cell responses of miR-155 deficient mice infected with 
LRV1+ L.g by measuring total serum anti-LRV1 capsid immunoglobulin G (IgG) 
titers. Infected miR-155-/- mice produced reduced titers of anti-LRV1 capsid IgG 
compared to infected WT mice (Figure S1C). These data suggested that B cells and 
the antibody response were not involved in the pathology of Leishmania infection, 
and were not essential for the LRV1+ L.g parasite resistant phenotype of miR-155-/- 
mice.  
It has also been reported that CD4+ T cells lacking miR-155 secrete more IL-4 but 
similar levels of IFN-γ compared to WT CD4+ T cells in in vitro differentiation 
conditions (Rodriguez et al., 2007). IFN-γ, which is predominantly secreted by CD4+ 
T cells, augments macrophage parasiticidal activity while IL-4 suppresses it (Sacks 
and Sher, 2002). Therefore, we evaluated the role of CD4+ T cells, which are 
required for controlling Leishmania parasites in our model of infection. To determine 
the impact of miR-155 on IL-4 and IFN-γ secreting CD4+ T cells during L.g infection, 
we used intracellular flow-cytometry analysis on the popliteal lymph node cells from 
WT and miR-155-/- mice infected either with LRV1+ L.g or LRV1- L.g at the peak of 
infection. Our results showed that the number and percentages of IFN-γ and IL-4 
secreting CD4+ T cells in LRV1+ L.g infected mice were similar compared to LRV1- 
L.g infected mice (Figures 2C and S2). These data indicated that the reduced 
disease progression in miR-155-/- mice in response to LRV1+ L.g did not arise from 
an IFN-γ /IL-4 imbalance. 
To further investigate the role of T cells in LRV1+ L.g infection, WT and miR-155-/- 
mice were injected with anti-CD4 depleting antibody 5 days prior to infection and on 
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a weekly basis until 6 weeks post infection (Figure S3A). We verified the efficiency 
of the antibody-mediated depletion using flow-cytometry (Figures S3B and S3C). 
Interestingly, CD4 depletion caused a significant decrease in footpad swelling at 2-3 
weeks post-infection both in LRV1+ L.g infected WT and miR-155-/- mice (Figure 
2D). We also observed that	the resolution of footpad swelling was impaired in both 
LRV1+ L.g infected WT and miR-155-/- mice after week 5 (Figure 2D). This data 
indicated that CD4+ cells contributed to lesion development early in LRV1+ L.g 
infection in a miR-155-independent manner and were required for the LRV1+ L.g 
infection resolution. 
We analyzed parasite load in CD4-depleted WT and miR-155-/- mice infected with 
LRV1+ L.g.  We found that CD4-depletion had no effect on parasite burden in WT 
mice but led to a significant increase in parasite load in LRV1+ L.g infected miR-155-
/- mice at the peak of infection (Figure 2E). These data suggested that CD4+ T cells 
were required for control of LRV1+ L.g during the earlier phases of infection in miR-
155-/- mice but not in WT mice that probably have a compensatory source of IFN-γ 
other than CD4+ T cells in this time frame.  
To better understand the possible impact of IFN-γ on the resistant phenotype of miR-
155-/- mice against LRV1+ L.g infection, we crossed miR-155-/- mice with mice 
lacking IFN-γ to generate IFN-γxmiR-155 double-knockout (DKO) mice and infected 
these mice with LRV1+ L.g parasites. Our data showed that the lesion size of 
infected IFN-γ-/- and DKO mice were similar and were higher than their IFN-
γ sufficient counterparts (Figure 2F). These findings showed that IFN-γ is essential 
for the clearance of L.g both in WT and miR-155-/- mice.  
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Macrophages lacking miR-155 do not exhibit any changes in the LRV1-
mediated hyper-inflammatory response  
TLR-3 recognition of LRV1 induces a hyper-inflammatory response in macrophages, 
leading to the secretion of pro-inflammatory cytokines and an increase in infection 
severity in mice (Ives et al., 2011). We thus tested whether a deficiency in miR-155 
expression could affect the LRV1-mediated pro-inflammatory cytokine profile in 
macrophages. BMMs were treated with poly I:C, or infected with LRV1+ L.g or 
LRV1- L.g. The supernatants were assayed for IL-6 and TNF-α. As shown 
previously, WT BMMs secreted IL-6 and TNF-α after 24 hours in the presence of 
poly I:C or LRV1+ L.g (Figure 3A). The TLR-3 activation of miR-155-/- BMMs yielded 
similar cytokine profiles to WT macrophages, providing evidence that miR-155 did 
not play a role in the inflammatory response to LRV1.  
We subsequently evaluated whether miR-155 deficiency had an impact on IRF3 
activation, which in turn could lead to a decrease in the mRNA and protein level of 
IFN-β. WT BMMs along with macrophages deficient in miR-155 or TLR3 were 
infected with LRV1+ L.g, LRV1- L.g, or treated with poly I:C. We observed that in the 
presence of LRV1+ L.g or poly I:C, IRF-3 phosphorylation occurred as early as 2 
hours following stimulation and became undetectable after 6 hours (Figure 3B). To 
compare the IRF3 phosphorylation levels between WT, TLR3-/- and miR-155-/- in 
response to infection, the cells were lysed 2 hours following infection. A change was 
not observed in IRF-3 phosphorylation in response to LRV1+ L.g infection or poly I:C 
between WT and miR-155-/- BMMs (Figure 3C). As expected, the phosphorylated 
form of IRF-3 was undetectable under all conditions in TLR3-/- infected macrophages 
(Figure 3C). Consistent with these findings, IFN-β was not significantly different 
between LRV1+ L.g infected WT and miR-155-/- macrophages at either the 
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transcriptional or protein level (Figures 3D and 3E). These data ruled out the 
hypothesis that the absence of miR-155 could decrease the hyper-inflammatory 
responses arising from the innate sensing of LRV1.  
 
LRV1+ L.g infection promotes activation of the PI3K/Akt signaling pathway  
The infection of macrophages with Leishmania parasites activates the PI3K/Akt 
signaling pathway (Ruhland et al., 2007), which is regulated, in part, by miR-155 in 
TLR-stimulated macrophages (O'Connell et al., 2009). We thus asked whether the 
infection of macrophages with LRV1+ L.g or LRV1- L.g promoted activation of Akt 
via miR-155. We analyzed Akt and its targets by immunodetection in cell lysates of 
BMMs incubated with medium, poly I:C, LRV1+ L.g or LRV1- L.g. At 2 hours post-
infection, the phosphorylation of Akt was increased in all conditions except in the 
medium-treated cells. Phosphorylated Akt levels in LRV1- L.g infected macrophages 
was reduced after 6 hours, but was still evident after 10 hours in LRV1+ L.g infection 
and poly I:C stimulation. Corresponding to these results, the level of pro-apoptotic 
Foxo3a gradually decreased in macrophages incubated with LRV1+ L.g or poly I:C, 
which is in accordance with a pro-survival effect of AKT (Litvak et al., 2012). We 
observed that the phosphorylation of GSK3-β was substantially greater in the 
presence of LRV1 or poly I:C at 6 hours post-infection when compared to LRV1- L.g 
infection (Figure 4A). We also detected an increase in mTOR and S6K 
phosphorylation in WT macrophages incubated with LRV1+ L.g, LRV1- L.g, or poly 
I:C for 2 hours (Figure 4A). Comparatively, we found higher levels of phosphorylated 
mTOR and S6K in macrophages incubated with LRV1+ L.g and poly I:C for 6 and 10 
hours (Figure 4A). Of note, we showed that LRV1 or poly I:C-mediated Akt 
activation in macrophages could be abrogated upon pre-treatment with the Akt 
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inhibitor MK2206, or the PI3K inhibitor wortmanin (Figure S4). Thus, L.g infection of 
macrophages promoted activation of the Akt dependent pro-survival signaling 
pathway, which was intensified and prolonged in the presence of LRV1.   
Since LRV1+ L.g infection elicited an increase in Akt phosphorylation in 
macrophages 10 hours post infection, we investigated the role of miR-155 and TLR-
3 in LRV1 mediated Akt activation. Protein levels of phosphorylated Akt and its 
targets were evaluated in WT, miR-155-/- and TLR3-/- macrophage lysates at 10 
hours post-infection. It was observed that LRV1 mediated-Akt activation and Akt-
dependent modulation of its targets relied on TLR-3, whilst miR-155 was partly 
involved in LRV1-mediated Akt activation (Figures 4B and 4C). Since miR-155 
deficiency in TLR-stimulated macrophages results in an approximately 1.5 fold-
increase in protein levels of the Src homology 2 domain-containing inositol-5-
phosphatase 1 (SHIP1), a negative regulator of the PI3K/Akt signaling pathway	
(O'Connell et al., 2009), we investigated the changes in the SHIP1 protein level in 
WT, miR-155-/- and TLR-3-/- macrophages in response to LRV1 at 24 hours post-
infection. As previously reported, we observed a 1.5 fold increase in the protein level 
of SHIP1 in LRV1+ L.g infected miR-155 deficient macrophages compared to their 
WT counterparts (Figure S5A and S5B), indicating that LRV1-mediated miR-155 
expression could induce Akt activation by modulating SHIP1 protein levels.  
To determine whether miR-155 contributed to Akt activation in infected animals, we 
performed flow-cytometry analysis to measure phosphorylated Akt levels in lesional 
macrophages from LRV1+ L.g or LRV1- L.g infected WT and miR-155-/- infected 
mice at 4 weeks post-infection (Figure S6). We found that lesional macrophages 
from infected miR-155-/- mice displayed a significant reduction in phosphorylated Akt 
levels in comparison to WT infected mice (Figure 4D), whereas no significant 
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difference was observed in LRV- L.g infected WT or miR-155-/- mice. Taken together, 
our results indicated that miR-155 was involved in the TLR-3 mediated activation of 
the pro-survival PI3K/Akt signaling pathway in macrophages infected with LRV1+ 
L.g.   
 
TLR-3 mediated cell survival is dependent on TLR ligand concentration and 
Akt activation  
Studies using knock-out animal models have shown that Leishmania molecules 
interact with several TLRs, however current knowledge on the identity and function 
of these molecules and their cognate TLRs is limited (Ives et al., 2014). Our results 
demonstrated that LRV1 drastically enhanced the L.g-mediated activation of the pro-
survival signaling pathway Akt, suggesting that the innate recognition of L.g through 
other TLRs could induce the activation of Akt. Thus, we raised the question on how 
TLR-mediated Akt activation affected the cellular fitness of macrophages in terms of 
cell survival. To this end, we performed high content microscope analysis of WT and 
miR-155-/- macrophages pretreated with DMSO or MK2206, an allosteric Akt 
inhibitor, and then incubated with various TLR and nucleotide-binding 
oligomerization domain-containing protein (NOD) ligands for 48 hours. We found that 
the ligation of certain TLRs did not induce cell survival such as TLR-1/2 and TLR-5 
(Figures 5A-B). In contrast, TLR-2/6, TLR-4, and TLR-7 ligation promoted 
macrophage survival. This effect was however not diminished by MK2206 pre-
treatment at higher concentrations of TLR ligand (Figures 5A-B). TLR-3 binding 
induced cell survival in a dose- and Akt-dependent manner, while Akt-dependent cell 
survival in the presence of TLR-2 and TLR-9 ligands was only observed at the 
highest agonist concentration. The fold change in WT macrophage numbers were 
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similar to miR-155 macrophage numbers in all conditions except for macrophages 
treated with the TLR-9 ligand ODN 2006 (Figures 5A-B). Taken together, these 
findings showed that the engagement of certain TLRs promoted macrophage 
survival in an Akt-dependent or –independent manner and this effect varied 
depending on the TLR-ligand concentration.  
 
LRV1+ L.g induced macrophage survival through the TLR-3/Akt axis is 
partially dependent on miR-155 
Our results demonstrated that TLR-3 stimulation promoted macrophage survival 
through the Akt signaling pathway. To determine whether LRV1 mediated-Akt 
activation promoted parasite persistence by inducing macrophage survival through 
miR-155 or TLR-3, BMMs were pre-incubated with DMSO or MK2206 and then 
infected with a multiplicity of infection (MOI) of 1 of L.g parasites either containing 
LRV1 or not. We found that the infection of WT and miR-155-/- macrophages with 1 
MOI of LRV1+ L.g increased macrophage survival. This effect was reversed by 
MK2206 pre-treatment in WT BMMs, but not in miR-155-/- and TLR-3-/- BMMs 
(Figures 6A-B). Confirming our previous work	(Zangger et al., 2014), the presence 
of LRV1 within parasites did not affect the parasite number per macrophage but 
infected macrophage survival (Figure 6C). Taken together, these results indicated 
that LRV1 dsRNA genome ligation to TLR-3 promoted macrophage survival and 
therefore parasite persistence by activating the Akt signaling pathway in a miR-155 
partially dependent manner.  
Discussion 
Our results demonstrated that LRV1 was able to exploit the TLR-3/miR-155/Akt 
signaling axis to enhance macrophage survival and persistence of intracellular 
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Leishmania parasites. Interestingly, the miR-155/Akt signaling pathway is known to 
cause myeloid proliferative disorder in both human and mice (O'Connell et al., 2008; 
Xue et al., 2014). However, a deficiency in the myeloid compartment is not observed 
in miR-155-/- mice under basal conditions (Rodriguez et al., 2007), suggesting that 
miR-155 function requires induction. It is known that miR-155 is the only microRNA 
up-regulated upon TLR-3 ligation in macrophages and that other TLR receptor 
agonists also promote miR-155 expression (O'Connell et al., 2007). Concurrently, we 
found that miR-155 was the only microRNA among 1179 miRNAs, which was 
significantly up-regulated in the presence of LRV1 in a TLR-3/TRIF dependent 
manner. We observed that LRV1- L.g infection only weakly induced miR-155 and 
BIC expression, suggesting that the innate recognition of parasites promoted only a 
slight increase in miR-155 expression through PRRs other than TLR-3. We found 
that mice deficient in miR-155 had significantly reduced disease pathology when 
infected with LRV1+ L.g, but not with LRV1- L.g. These results indicated that LRV1 
used host miR-155 as a persistence mechanism, a situation evocative of certain 
Herpesviruses which exert their virulence via the pathogenic overexpression of miR-
155 from either viral- or host-origin (Gottwein et al., 2007; Linnstaedt et al., 2010; 
Zhao et al., 2011). In this regard, whether other protozoan parasites containing 
viruses belonging to the Totiviridae family can subvert the host immune system 
through TLR-3/miR-155 remains to be determined. 
MiR-155 deficiency in mice was shown to be protective against T- and B-cell driven 
autoimmune disorders such as rheumatoid arthritis (Bluml et al., 2011; Kurowska-
Stolarska et al., 2011), experimental autoimmune encephalomyelitis (O'Connell et 
al., 2010), and systemic lupus erythematous (Thai et al., 2013). However, 
interestingly, in serum or autoantibody transfer arthritis models, which are 
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predominantly driven by innate cells, the severity of joint inflammation is not different 
between WT and miR-155-/- mice (Bluml et al., 2011; Kurowska-Stolarska et al., 
2011). In addition, WT and miR-155-/- macrophages secrete similar levels of TNF-α 
after in vitro stimulation with autoantibody immune complexes (Kurowska-Stolarska 
et al., 2011). Other studies show that the impact of miR-155 on the pro-inflammatory 
cytokine profile of LPS-stimulated macrophages (Androulidaki et al., 2009) and other 
cell types (Tili et al., 2007) at the protein level by transfecting a microRNA mimic or 
antagonist. However, we did not observe a difference in the pro-inflammatory 
cytokine profile between WT and miR-155-/- primary murine macrophages in 
response to poly I:C or LRV1+ L.g infection in terms of the secretion of pro-
inflammatory cytokines (TNF-α, IL-6 and IFN-β), the expression of IFN-β mRNA, and 
the phosphorylation of IRF-3. These results might be explained by the difference in 
stimuli, but it should be noted that transfecting microRNA mimics or antagonists 
could cause an increase in the expression of endogenous microRNA targets due to 
the overexpression-mediated saturation of the intracellular protein complex which 
guides microRNAs to its target mRNA (Khan et al., 2009). 
We found that IFN-γ and IL-4 secreting CD4+ T cell numbers of LRV1+ L.g infected 
WT mice were not different from LRV1+ L.g infected miR-155-/- mice at the peak of 
infection, although, it was previously shown that CD4+ T cells of miR-155 deficient 
mice secrete more IL-4 and similar levels IFN-γ under in vitro differentiation 
conditions (Rodriguez et al., 2007). However, the IFN-γ and/or IL-4 secretion of ex 
vivo WT and miR-155 CD4+ T cells were found to be similar in different biological 
settings (Kurowska-Stolarska et al., 2011; O'Connell et al., 2010), suggesting that 
miR-155 affects CD4+ T cell plasticity in a condition-specific manner. Interestingly, 
we showed that CD4+ cells mediated footpad swelling in mice infected with LRV1+ 
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L.g through miR-155-independent mechanisms. Thus, further studies are required to 
understand the role of CD4+ T cell lineages in this miR155-independent LRV1-
mediated disease pathology. 
We demonstrated that miR-155-/- mice, unlike WT mice, required CD4+ T cells to 
control parasite growth early on infection. Further, it is known that miR-155 
deficiency impairs the effector function of other-IFN-γ-producing cells, such as NK 
cells	(Trotta et al., 2012), which can play a compensatory role in the restriction of 
parasite growth in the absence of CD4+ T cells in the early phases of infection 
(Scharton and Scott, 1993). In our study, we found that both WT and miR-155-/- mice 
were not able to control LRV1+ L.g infection in the absence of IFN-γ mediated 
immune pressure,	suggesting that IFN-g is absolutely essential to control infection 
either in WT or in miR-155-/- mice.	
Several reports have proposed that the infection of macrophages with Leishmania 
spp. promotes parasite persistence by enhancing macrophage survival	(Akarid et al., 
2004; Moore and Matlashewski, 1994; Moore et al., 1994; Ruhland et al., 2007). 
Addressing the question on how the innate recognition of LRV1 modify host cells to 
induce the survival of its microbial host, we found that LRV1 induced the 
phosphorylation of the pro-survival protein kinase Akt through TLR-3 in a miR-155 
partially dependent manner. Consistent with a previous study, our findings supported 
that miR-155 could modulate the PI3K/Akt signaling pathway by regulating SHIP1 
protein expression (O'Connell et al., 2009). Functionally, our data showed that 
neither the LRV status of L.g nor deficiency of TLR-3 and miR-155 in macrophages 
had an impact on the number of parasites per macrophage in vitro. We cannot, 
however, exclude the involvement of TLR-3 expressing phagocytic cells, other than 
macrophages, which can act as host cells for Leishmania parasites, in the miR-155 
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deficiency mediated protection against LRV1+ L.g infection in mice. Nonetheless, 
our findings revealed a virulence mechanism in LRV1+ L.g infection, whereby LRV1 
conferred a survival advantage to its parasite host by promoting the survival of 
infected macrophages, which are the definitive host cells for Leishmania, through a 
TLR3/miR-155/Akt signaling circuit. These results highlighted the potential clinical 
importance of oncogenic kinases during leishmaniasis, and identified several 
potential therapeutic targets to treat and prevent the disfiguring complications of 
cutaneous leishmaniasis. 
Experimental Procedures 
Animals 
All animal protocols described in this report were approved by the Swiss Federal 
Veterinary Office (SFVO), under the authorization numbers 2113.1 and 2113.2. 
Animal handling and experimental procedures were undertaken with strict adherence 
to ethical guidelines set out by the SFVO and under inspection by the Department of 
Security and Environment of the State of Vaud, Switzerland. Details are given in the 
Supplemental Experimental Procedures. 
Parasite Culture 
Parasites were cultured at 26°C in complete Schneider’s medium with L-glutamine 
(Sigma-Aldrich®), supplemented with 1% penicillin/streptomycin (Amimed®) and 
20% Fetal Calf Serum (FCS) (PAA®). The parasites were passaged in culture for not 
more than 5 passages, and isolated from mouse footpads to maintain their virulence. 
Details are given in the Supplemental Experimental Procedures.  
Macrophage infection  
The femurs and tibias of naïve mice were washed with medium containing 1% P/S to 
extract cells, which were differentiated into bone marrow derived macrophages 
 19		 	
(BMMs) for 6 days using complete DMEM supplemented with L-929 (EACC cell line, 
Sigma-Aldrich®) conditioned media at 37oC. BMMs were seeded on culture plates, 
and incubated overnight. BMMs were infected with stationary phase LRV1+ or 
LRV1- L.g at MOI of 10 parasite per macrophage, unless otherwise indicated. BMMs 
were also treated with poly I:C (Invivogen®) at 2µg/ml or pretreated with DMSO 
(Sigma-Aldrich®) or 5µM MK2206 (Apexbio) for 1 hour.  
MicroRNA microarray  
Four independent experiments were performed. In each experiment, macrophages 
derived from 2 individual C57BL/6 mice were either infected with LRV1+ ,or LRV1- 
L.g ,or lysed with RNAzol®RT (Mrcgene) after 10 hours post infection. As a control, 
macrophages were treated with medium or poly I:C for post-array verification by RT-
PCR. Total RNA was isolated from samples and microRNA microarray (Agilent 
mouse miRbase v18.0) was performed following the manufacturer’s instruction. 
Details are given in the Supplemental Experimental Procedures. 
The quantification of microRNA and mRNA using quantitative real time-PCR 
The miR-16 and miR-155 levels were quantified with stem-loop RT-PCR. The 
abundance of mRNA and pre-miRNA were quantified with RT-PCR using Taqman® 
probe or SYBR Green (Roche®)-based detection. The results were normalized 
against 60S ribosomal protein L32 (L32) for mRNA and miR-16 for microRNA. 
Details are given in the Supplemental Experimental Procedures. 
Mice infection and the quantification of parasite burden by bioluminesence 
Age-matched mice were infected with 1x106 stationary Leishmania parasites in both 
hind footpads of mice. Change in footpad thickness was monitored on a weekly 
basis. As described previously (Ives et al., 2011), parasite burden were quantified in 
mice by intra-peritoneally injecting D-Luciferin sodium salt (Regis Technologies®) in 
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1xPBS at a concentration of 150mg/kg. The images were acquired and analyzed 
using a Xenogen Lumina II imaging system (IVIS®); Living Image® software. Mice 
were anesthetized with isofluorane during the image acquisition. Oval region of 
interest (ROI) were set on footpads and the tail to determine the parasite burden or 
the background, respectively. Bioluminescent signals were expressed in units of 
photons per second (P/s). 
Flow cytometry analysis  
Popliteal lymph nodes (PLNs) or footpad lesions (FLs) were harvested from infected 
mice at the peak of infection. A single cell suspension was prepared from FLs and 
PLNs with or without collagenase /DNAseI treatment, respectively. Cells isolated 
from PLNs were counted before PMA/ionomycin in vitro stimulation. Extracellular 
staining was performed using anti-mouse CD4 and CD8 antibodies. Cells were 
intracellulary stained for IFN-γ and IL-4 cytokines using an intracellular fixation and 
permeabilization buffer set, following manufacturer`s instructions (eBioscience®). 
Cells isolated from FLs were fixed and permeabilized as described before (Krutzik 
and Nolan, 2003), followed by staining with CD45, CD11b, CD11c, F4/80 and p-Akt 
(T308) antibodies. Samples were acquired in BD FACSVerse™ or LSR II flow 
cytometry, and analyzed using FlowJo software. Details are given in the 
Supplemental Experimental Procedures. 
In vivo depletion of CD4 cells 
Anti-CD4 GK1.5 monoclonal antibody was purified from hybridoma (GK1.5; ATCC) 
culture supernatant using affinity chromatography on HiTrap Protein-G columns 
(Amersham-Pharmacia, Freiburg, Germany). Mice were intraperitoneally injected 
with 500µg anti-CD4 GK1.5 antibody 5 days prior to infection and on a weekly basis 
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until 7 weeks post- infection. The splenocytes of mice were harvested to verify the 
efficiency of antibody-mediated depletion using flow cytometry.  
The quantification of cytokine concentration in in vitro culture 
The concentrations of TNF-α (eBioscience®), IL-6 (eBioscience®), and IFN-β (PBL, 
Interferon Source) in collected supernatants from treated macrophages were 
determined using enzyme-linked immuno-sorbent assay (ELISA) following 
manufacturer’s instructions. The plates (Nunc-Immuno™) were read on a Synergy™ 
HT Multi-Mode Plate Reader (Biotek Instruments, Switzerland). Wavelength 
correction and background signals were subtracted from the absorbance values.  
Western blot analysis 
Cells were lysed using cell lysis buffer containing protease/phoshotase inhibitors. 
Cell lysates were run on SDS-PAGE, transferred to nitrocellulose membrane, and 
analyzed by Western blotting using antibodies specific for the indicated antigens. 
Details are given in the Supplemental Experimental Procedures. 
High Content Microscopy 
BMMs were counted with Vi-Cell® (Beckman Coulter) then seeded on 96 well tissue-
culture treated clear bottom plates (Falcon®). After overnight incubation, cells were 
treated with DMSO (Sigma-Aldirich), or 5µM MK2206 (ApeXBio) for 1 hour. 
Subsequent to a washing step, BMMS were treated with ligands in Multi-TLR array 
(Invivogen®) medium, poly I:C (2 µg/ml), LRV1+ L.g or LRV1- L.g for 48 hours. Cells 
were fixed with freshly made %3.7 PFA in 1x PBS pH 7.4, stained with DAPI 
(Molecular Probes®) and Alexa488-Phalloidin (Molecular Probes®) then washed 
with 1xPBS using a Biotek® MultioFlo FX plate washer. 49 (7x7 square, total area 
0.12mm2). Images were acquired from each well using ImageXpress Micro XLS, and 
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cell and parasite numbers were counted using an automated software program 
(MetaExpress®).  
Accession Number 
The ArrayExpress accession number for the microRNA microarray is E-MTAB-4413. 
Statistical Analysis 
All graphs were generated in GraphPad Prism. Unpaired Student’s t-test and 
repeated measure two-way ANOVA tests were performed using Microsoft Excel and 
GraphPad Prism, respectively. We considered P<0.05 and P<0.001 for unpaired 
Student’s t-test and repeated measure two-way ANOVA test with Bonferroni’s post-
test to be statistically significant, respectively. NS stands for a non-significant 
statistical difference. P values are shown as * for P<0.05, ** for P<0.01 and *** for 
P<0.001. 
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Figure Legends 
Figure 1. LRV1 induced miR-155 expression through TLR-3/TRIF signaling 	
(A) MicroRNA microarray analysis was performed on total RNA extracted from WT 
BMMs infected with LRV1+ L.g and LRV1- L.g for 10 hours. Scatter plot shows log10-
transformed normalized averaged intensity values (n=4) for each miRNA probe.  
(B) A portion of WT BMMs generated in (A) were treated with medium or poly I:C 
(2µg/ml). RT-PCR was used to measure the abundance of the miR-155 in extracted 
RNA. The numbers represent relative miR-155 expression as fold induction over the 
medium treated condition subsequent to normalization with miR-16.  
(C and D) Kinetic quantification of miR-16-normalized miR-155 (C) and L32-
normalized BIC (D) expression in WT BMMs incubated with medium, poly I:C 
(2µg/ml), LRV1+ L.g or LRV1- L.g using RT-PCR.  
(E) β-galactosidase western blot analysis of miR-155-/- BMMs infected with LRV1+ 
L.g (+) or LRV1- L.g (-) at indicated time points. Cells treated with medium (as 
negative control) or with poly I:C (2µg/ml) (as positive control) were also blotted for 
β-galactosidase.  
(F) The relative miR-155 expression levels of WT, TLR-3-/- and TRIFΔLPS2 
macrophages incubated with medium, poly I:C (2µg/ml), LRV1+ L.g or LRV1- L.g.  
Data are presented as mean ± SEM from the pool of three independent experiments 
(C, D and F). Representative western blots were shown from three independent 
experiments (E). P values shown were calculated unpaired Student’s t-test. ** 
P<0.01 and *** P<0.001. 
Figure 2. MiR-155-/- mice infected with LRV1+ L.g parasites had decreased 
disease pathology when compared to WT mice    
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(A and B) Hind footpads of WT and miR-155-/- mice were infected with 1x106 LRV1+ 
L.g or LRV1- L.g.  
(A) The graph displays the weekly measurement of footpad swelling. 
(B) Parasite burden was determined at 3 weeks after infection by bioluminescence 
imaging.  
(C) Popliteal lymph nodes were collected from WT and miR-155 mice infected with 
LRV1+ L.g or LRV1- L.g on the footpad after 3 weeks infection. Intracellular FACS 
analysis was performed using primary ex vivo lymphocytes extracted stimulated with 
PMA/ionomycin to measure IL-4 and IFN-γ levels in CD4+ T cells (see also Figures 
S2).  
(D-E) Mice were intraperitoneally injected with CD4-depleting antibody 5 days prior 
to LRV1+ L.g infection and then on weekly basis for 6 weeks. A group of mice were 
treated with PBS as a negative control (see also Figures S3 and S4).  
(D) Footpad swelling of LRV1+ L.g infected WT and miR-155-/- mice.  
(E) Parasite load was measured by bioluminescence 4 weeks post-infection.  
(F) The measurement of footpad swelling in WT, miR-155-/-, IFN-γ and IFN-γxmiR-
155 DKO mice following of LRV1+ L.g infection. 
Data shows mean ± SD from representative experiments (n= 4-5 mice) of two (C-E) 
or three (A, B, F) independent experiments. Each dot in the scatter blot represents a 
footpad (B and E). Statistical significance is calculated using two-way ANOVA 
analysis with Bonferonni’s posttest (A and D) and unpaired Student’s t-test (B and 
E). Not significant (ns), * P<0.05, and *** P<0.001. See also Figure S1.  
Figure 3. MiR-155-/- macrophages exhibited similar proinflammatory cytokine 
response compared to WT macrophages in response LRV1+ L.g or poly I:C 
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(A-E) BMMs were infected with LRV1+ L.g (+) or LRV1- L.g (-). Cells were treated 
with medium or poly I:C (2 µg/ml) as a control for indicated times. 
(A) The cell-free culture supernatant was collected 24 hours post-treatment from 
treated macrophages derived from WT, TLR-3-/- and miR-155-/- mice were assayed 
for IL-6 and TNF-α using ELISA.  
(B) Total cell lysate of treated WT macrophages was analyzed by Western blot with 
IRF3-P, IRF-3, and γ-tubulin after 2, 6, and 10 hours infection.  
(C) WT, TLR-3-/- and miR-155-/- BMMs were lysed after 2 hours and immunoblotted 
for the indicated antibodies.  
(D) IFN-β mRNA levels were assayed after 2 hours incubation using RT-PCR. 
Values were normalized using L32. Transcript levels were calculated relative to 
unstimulated WT macrophages.  
(E) Protein level of IFN-β was quantified in collected cell culture medium after 6 
hours treatment.  
Data are mean ± SD from three pooled independent experiments. Representative 
blots were showed from three independent experiments. 
Figure 4. MiR-155 partially contributed TLR-3 dependent-Akt activation 
(A-B) Macrophages incubated with medium, poly I:C, LRV1+  L.g (+), or LRV1- L.g (-
) for indicated time(s). Cells were lysed and total protein lysates were immunoblotted 
for Foxo3a, GSK3-β, phosho-GSK3-β (Ser9), Akt, phosho-Akt (T308), S6K, phosho-
S6K (Thr389), mTOR, phosho-mTOR (Ser2448) and γ-tubulin.  
(A) Whole-cell lysate of WT macrophages after 2, 6, and 10 hours post-treatment 
were immunobloted for the indicated proteins.  
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(B) Macrophages derived from WT, TLR-3-/- and miR-155-/- mice were incubated with 
indicated conditions for 10 hours, and whole cell lysates of indicated samples were 
subjected to western blot analysis with the indicated antibodies.  
(C) Cell lysates described in (B) were immunoblotted for Akt, phosho-Akt (T308) and 
γ-tubulin. The levels of Akt (Thr308) phosphorylation were quantified by 
densitometric analysis. The data were normalized with total Akt and shown as fold 
increase of normalized Akt phosphorylation over Akt (T308) / Akt from medium-
treated macrophages.  
(D) Flow-cytometry analysis of the mean fluorescence intensity (MFI) of 
phosphorylated Akt (T308) in CD45+ CD11b+ CD11c- F4/80+ lesional macrophages 
from LRV1+ L.g or LRV1- L.g infected WT and miR-155-/- mice at 4 weeks post-
infection. See also Figure S6. 
Representative blots (A-B) and quantification (C) from at least three independent 
experiments are shown. The graph (D) shows pooled data from two independent 
experiments (n=2-5 mice). Data is expressed as mean ± SD. Unpaired Student’s t-
test was used to measure statistical significance. Not significant (ns) and * P<0.05. 
See also Figure S3 and S4. 
Figure 5. TLR-3 induced macrophage survival in an Akt-dependent manner 
(A-B) WT (A) and miR-155-/- (B) macrophages were seeded in 96-well plate and 
were pre-cultured with DMSO or MK2206 for 1 hour. Cells were treated with series of 
three ten-fold dilutions of TLR ligands, and were fixed after 48 hours. Macrophages 
were stained with DAPI (nucleus) and phalloidin (cytoskeleton), and were analyzed 
with high-content microscope. Images are in phalloidin channel and display an entire 
96 well plate. Each square (352µMx352µM) represents a well composing of 49 (7x7) 
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pictures taken by x40 lens. The fold increase in cell number were calculated by 
normalizing sample cell counts to the cell numbers within DMSO-treated well.  
Data represent mean ± SD from two independent experiments with three biological 
replicates. See also Table S1.  
Figure 6. LRV1 exploited TLR-3/miR-155/Akt pathway to promote the 
persistence of its microbial host 
(A-C) WT, TLR-3-/- and miR-155-/- macrophages were infected with promastigotes of 
LRV1+ or LRV1- L.g at 1 MOI for 48 hours. Cells were fixed and processed for high-
content analysis by staining with DAPI and phalloidin.  
(A) A representative composite image of a well containing 7x7 pictures with 
352µMx352µM images from each condition were displayed in phalloidin channel.  
(B) Relative macrophage number was quantified by normalizing cell numbers of the 
samples to the cell count of the medium-treated WT macrophages.  
(C) Parasite load in macrophages described in (B) were quantified.  
Mean ± SD were calculated from two independent experiments with three biological 
replicates in triplicate. Data were analyzed unpaired Student’s t-test. Not significant 
(ns), * P<0.05, ** P<0.01 and *** P<0.001.	
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Highlights  
• TLR-3 recognition of Leishmania RNA virus (LRV) induces miR-155 expression.  
• MiR-155-/- mice show decrease in the pathogenesis of LRV+ Leishmania infection.  
• LRV induces the activation of PI3K/Akt signaling through TLR-3 and miR-155.  
• LRV promotes parasite persistence by inducing host cell survival via Akt.  
 
In Brief (eTOC blurb) 
The viral endosymbiont of Leishmania parasites enhances virulence of its microbial 
host by promoting hyperinflammation through TLR-3. Eren et al. show an additional 
virulence mechanism wherein virus-containing Leishmania exploits innate receptor 
signaling pathways at a microRNA level, promoting macrophage survival and 
consequently parasite persistance through a TLR-3/miR-155/Akt signaling axis.	
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Figure S1, Related to Figure 2C. B cell responses does not affect LRV1-mediated disease progression.
(A-C) The hind footpads of mice were infected with 1.0x106 stationary LRV1+ L.g prosmatigotes.
(A) The footpad swelling of infected WT and Jh-/- were monitored weekly during the course of infection. The graph 
is representative of two independent experiment.
(B) The parasite burden in 4-weeks infected WT and Jh-/- were determined using relative luminescence.
(C) Total serum anti-LRV1 capsid IgG antibody titers of blood samples obtained from LRV1+ L.g infected (n=3) or 
naïve (n=2) WT and miR-155-/- were measured using indirect ELISA against LRV1 capsid. Serums were diluted by 
two-fold serial dilutions in ELISA Diluent Solution (eBioscience®).
Data (A-B) are expressed as mean ± SD and is representative of three (A) or two (B) independent experiment. 
Unpaired Student’s t-test was used for evaluation of statistical significance. Not significant (ns).
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Figure S2, Related to Figure 2C. L.guyanensis infected WT and miR-155-/- mice has similar levels of IL-4 and 
IFN-γ secreting CD4+ T cells at the peak of infection.
WT and miR-155-/- mice were infected with 1.0x106 LRV1+ L.g or LRV1- L.g from the footpad. Popliteal lymph nodes 
were harvested at the peak of infection and dissociated to single cell suspension. Cells were stained for surface marker 
CD4 and for IFN-γ and IL-4 cytokines intracellularly. As a control, cells were stained with isotype-matched controls 
for IFN-γ or IL-4.
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Figure S3, Related to Figures 2D and 2E. The FACS analysis of CD4 depleted mice splenocytes.
(A-C) WT and miR-155-/- were treated with PBS or CD4 depleting antibody 5 days prior to LRV1+ L.g or LRV1- L.g 
infection and weekly afterwards (A). The flow cytometry analysis of splenocytes from treated mice at the day of infection 
(B) or at the end of the infection (C) for CD4 and CD8 T cell subsets was performed.
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Figure S4, Related to Figure 4. The inhibition of PI3K diminishes LRV1+ L.g and poly(I:C)-mediated Akt 
activation.
WT macrophages were pre-treated with DMSO (D), 5μM MK-2206 (M) or 100nm Wortmanin (W) for 1 hour 
before the addition of indicated treatments. After 10 hours treatment, the protein levels of indicated proteins were 
assayed by immunoblotting. Representative blot were shown from three independent experiments.
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Figure S5, Related to Figure 4. Macrophages lacking miR-155 have increased amounts of SHIP1 protein in 
response to LRV1+ L.g infection.
(A-B) WT, miR-155-/- and TLR-3-/- macrophages were incubated with medium, LRV1+ L.g or LRV1- L.g for 24 
hours. Cell were lysed and subjected to Western blot analysis to monitor the expression of SHIP1. Images were 
acquired and quantified using Licor Odyssey® CLx system.
(A) A representative blot is shown for SHIP1 expression.
(B) The blots were quantitated after being normalized to γ-tubulin, and fold-increase over WT medium treated is 
shown in bar graph. Data represents as mean ± SD of three independent experiments performed in duplicate.
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Figure S6, Related to Figure 4D. The gating strategy to measure phoshorylated-Akt in macrophage population in 
footpad lesion tissue of infected mice. 
Footpad lesions harvested from mice infected 4 weeks with Leishmania guyanesis parasites were analyzed using 
flow-cytometry. The gating strategy is shown for the analysis of phosphorylated Akt at threonine 308 (p-Akt T308) residue 
in lesional macrophage population, as identified by expression of CD45, CD11b, CD11c and F4/80. Representative 
flow-cytometry histogram overlay of p-Akt (308) expression (red) and fluorescence-minus-one control (black) is shown 
for the indicated cell population.
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Table S1, Related to Figure 5. Layout of multi-TLR array for high content microscopy. 
The table displays the concentrations of pathogen-associated receptors (PRRs) cognate ligands that were used to 
stimulate macrophages in 96-wells high content imaging plates. The first three rows contain the information on 
PRRs, their cognate ligands, and units, respectively.  
 
Supplemental Experimental Procedures 
 
Measurement of total serum immunoglobulin G against LRV1 capsid 
Plates (Nunc-Immuno™) were coated with LRV1 capsid protein at a concentration of 5µg/ml by incubating 
overnight at 4°C in 1xPBS.  Plates were blocked with 1xAssay diluent (eBioscience) and incubated for 1 hour at 
room temperature. Blood samples were collected from mice under deep terminal anesthesia by cardiac puncture. 
Using these blood samples, a series of two-fold dilutions of serum in 1x Assay diluent (eBioscience) were 
prepared and incubated in coated/blocked plates for 2 hours at room temperature. The plates were incubated 
sequentially with biotin conjugated anti-mouse IgG (Jackson ImmunoResearch, USA) and streptavidin-
conjugated HRP (eBioscience), followed by horseradish peroxidase (HRP)-substrate TMP. The colorimetric 
reaction was stopped by adding sulfuric acid and was detected at 450nm using a Synergy™ HT Multi-Mode 
Plate Reader (Biotek Instruments, Switzerland). 
 
Technical details of animals 
C57BL/6 mice were purchased from Harlan Laboratories (Netherlands). TLR3−/− mice or miR-155−/− mice were 
obtained from Prof. S. Akira (Osaka University, Japan) via P. Launois (WHO-IRTC, Lausanne,Switzerland) or 
Prof. Klaus Rajewsky (Max Delbrück Center for Molecular Medicine, Berlin, Germany) via Prof. Hans Acha-
Orbea (UNIL, Lausanne, Switzerland). TRIFΔLPS2 mice were obtained via B. Ryffel, (CNRS, Orléans,France). 
Jh-/- mice and IFN-γ-/- mice were obtained from Jackson Laboratories (United States).  IFN-γxmiR-155 DKO 
mice were produced by intercrossing IFN-γ-/- and miR-155-/- mice. Mice were genotyped by PCR on tissue-
isolated genomic DNA using the KAPA Mouse Genotyping Kit (KAPA Biosystems, USA). Mice were 
maintained under pathogen-free conditions at the animal facility of the Center of Immunity and Immunology, 
Lausanne (Switzerland). The mice and all experiments were performed under the guidelines set by the State 
Ethical Committee for the utilization of laboratory animals. All mice were backcrossed to C57BL/6 background 
for at least eight generations. 
 
Primers used for mice genotyping 
IFN-γ-/- 5’ - CCT TCT ATC GCC 
TTC TTG ACG-3’ 
5’ - AGA AGT AAG TGG 
AAG GGC CCA GAA G-3’ 
5’ - AGG GAA ACT GGG 
AGA GGA GAA ATA T-3’ 
miR-155-/- 5’ - GTG CTG CAA ACC 
AGG AAG G-3’ 
5’ - CTG GTT GAA TCA 
TTG AAG ATG G-3’ 
5’ - CGG CAA ACG ACT 
GTC CTG GCC G-3’ 
 
Technical details of MicroRNA microarray 
The quality of RNA was checked using Agilent 2100 bioanalyzer and spectrophotometer. Agilent microRNA 
microarray 8x15K based on Sanger miRBase Release 18.0 was used. MicroRNA microarray was performed, 
acquired, and analysed by Lausanne Genomic Technology Facility (LTGF), University of Lausanne, 
Switzerland. Briefly, 100 ng RNA were hybridized after the labeling reaction with Cyanine-3 (Cy-3) using the 
miRNA Complete Labeling and Hyb Kit (Agilent Technologies), according to the manufacturer’s instructions. 
The array was acquired using DNA microarray scanner (Agilent Technologies), and the raw data were 
processed using Agilent Feature Extraction software (Version 10.7.3.1). The data were normalized and analyzed 
using R language software (Version 3.0.1); Bioconductor package preprocessCore Analysis and Bioconductor 
package limma. Moderated t-test was performed to compare the microRNA expression profile of macrophages 
infected with LRV1+ L.g to those with LRV1- L.g. P-values were adjusted with the Benjamini-Hochberg 
method, controlling for false discovery rate (FDR). 
 
Technical details of the flow cytometry analysis  
1x106 cells in single cell suspension prepared from popliteal lymph nodes of infected mice were plated and 
stimulated with a cocktail containing PMA (50ng/ml), ionomycin (1µg/ml), and brefeldin A (100ng/ml) for 3 
hours at 37oC. Prior to the staining procedure, cells were incubated with 2.4G2-conditioned medium to block 
CD16/32. Cells were first extracellularly stained for CD4 (Clone RM4.5 eBioscience®) and CD8 (Clone 53-6.7, 
Biolegend®), and were fixed and permeabilized using intracellular fixation and permeabilization buffer set 
according to the manufacturer`s instructions (eBioscience). Cells were stained with IFN-γ (Clone XMG1.2 
eBioscience) and IL-4 (Clone 11B11 eBioscience) or the matching Ig isotype antibodies.  
Harvested footpad lesions from mice were cut into small pieces and treated with collagenase A (0.5 mg/ml; 
Boehringer-Mannheim, Mannheim, Germany) and DNase I (40 mg/mL; Boehringer-Mannheim) in DMEM 
medium supplemented with %5 FCS for 45 minutes at 37°C. Single cell suspension were prepared from samples 
using a dounce tissue grinder, and cell suspensions were filtered through a 40µM cell strainer. Cells were fixed 
in 1.5% paraformaldehyde in 1x PBS, pH 7.4 for 10 minutes and were permeabilized with methanol. Before 
staining, the samples were washed twice with 1xPBS, pH 7.4 supplemented with 1%BSA. Stainings were 
performed using CD45 (Clone 30-F11, eBioscience) , CD11b (Clone M1/70, Biolegend), CD11c (Clone N418, 
Biolegend), F4/80 (Clone BM8, Biolegend) and p-Akt (T308) (Clone C31E5E, CST) in 1%BSA/1xPBS.  
 
Technical details of the quantification of microRNA and mRNA using quantitative real time-PCR 
Stem-loop RT-PCR was performed as previously described (Hurley et al., 2012). Briefly, total RNA was reverse 
transcribed using a specific stem-loop primer that anneals to 6 nucleotides of 3’ miRNA. The abundance of 
product cDNA were measured by performing a RT-PCR reaction containing miRNA-specific forward primer, 
universal reverse primer, and locked-nucleic acid (LNA) based hydrolysis probe (Roche, UPLTM No.21, 
Switzerland). 
 
Primers used for stem-loop RT-PCR 
MiR-155 stem loop primer 5’ - GTT GGC TCT GGT GCA GGG TCC GAG GTA TTC GCA CCA GAG 
CCA ACA CCC CTA T - 3’ 
MiR-155 forward primer 5’ - ACA CCA CGC ATT AAT GCT AAT TGT GAT -3’ 
MiR-16 stem-loop primer 5’ - GTT GGC TCT GGT GCA GGG TCC GAG GTA TTC GCA CCA GAG 
CCA ACC GCC AAT A - 3’ 
MiR-16 forward primer 5’ - ACA CAC GCA TAG CAG CAC GTA AAT AT -3’ 
Universal reverse primer 5’ - GTG CAG GGT CCG AGG T - 3’ 
 
Total RNA was collected by RNAzol® RT (Mrcgene). RNA was reverse-transcribed using the PrimeScript™ 
RT Reagent Kit with gDNA Eraser (Takara;Clontech Inc., USA). RT-PCR was performed on complementary 
DNA (cDNA) using following primers: 
 
Primers used for RT-PCR 
Gene Taqman® Catalog 
No. 
Forward Primer Reverse Primer 
IFN-β Mm00439552_s1   
L32   5’- AAG CGA AAC TGG CGG 
AAA C - 3’ 
5’-	  TAA CCG ATG TTG GGC 
ATC AG -3’ 
BIC  5’- TTG GCC TCT GAC TGA CTC 
CT - 3’ 
5’- GCA GGG TGA CTC TTG 
GAC TT -3’ 
 
Data were acquired using LightCycler® 480 (Roche) and analyzed with the 2-ΔΔCt method. Data were normalized 
to L32 expression and samples were calibrated to the expression of the gene of interest in medium-treated 
BMMs.  
 
Technical details of Western blot analysis 
Cells were lysed with lysis buffer after 2, 6 or 10 hours post-treatment. Cell lysis buffer was composed of 5x 
RIPA Buffer IV (Bio Basic Inc., Canada), 100x Protease/Phosphatase inhibitor cocktail (CST). Cell lysates 
were centrifuged at 13.000xg for 10 minutes.  4x Laemmli’s Sample Buffer was added to the supernatant. Cells 
lysates were size-fractionated by SDS-PAGE and wet-transferred to a nitrocellulose membrane. The membranes 
were blocked with 5% milk in Tris buffered saline with 0.1% tween-20 (TBST), and were incubated with 
primary antibody and with appropriate secondary antibody conjugated to HRP or IRDye® 800CW. The 
membranes were washed with TBST in between incubations. The immunoblot was revealed by the enhanced 
chemiluminescence Western blotting detection (GE Healthcare, UK) or with the Licor Odyssey® CLx system. 
The films (Amersham HyperfilmTM, GE Healthcare or SuperRX, Fuji, Japan) were developed using a 
radiograph (SRX-101a, Konica Minolta). Phosho-Akt (Thr308)/Akt ratio was quantified with densitometry 
analysis using Image J software. 
 
Antibodies used for Western blots 
Name of Antigen Source Catalog No. 
Akt CST 4691 
Phosho-Akt (Thr308) CST 2965 
Foxo3a CST 2497 
GSK3-β CST 9315 
Phosho-GSK3-β (Ser9) CST 5558 
IRF-3 CST 4302 
Phosho-IRF-3 (Ser396) CST 4947 
m-TOR CST 2983 
Phosho-m-TOR (Ser2448) CST 5536 
p70 S6 kinase (S6K) CST 9202 
phosho-S6K (Thr389) CST 9234 
β-galactosidase Promega® Z3781 
γ-tubulin Sigma-Aldrich® T6557 
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